Quantrx Biomedical Corp (QTXB) financial statements (2022 and earlier)

Company profile

Business Address P.O. BOX 4960
TUALATIN, OR 97062
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 55130322460161
Cash and cash equivalents 55130322460161
Prepaid expense  738282826
Deposits current assets      50
Other undisclosed current assets    403  
Total current assets: 5513736089129137
Noncurrent Assets
Property, plant and equipment      1
Long-term investments and receivables   222500170200
Long-term investments   222500170200
Intangible assets, net (including goodwill)    (101)1420
Intangible assets, net (excluding goodwill)    (101)1420
Other undisclosed noncurrent assets    101  
Total noncurrent assets:   222500184221
TOTAL ASSETS: 551375821,391213359
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 88371375195197156
Accounts payable 164849168161122
Accrued liabilities   26273634
Interest and dividends payable 866665    
Debt 1,3881,3881,8711,8251,095814
Due to related parties 166147  283
Other undisclosed current liabilities  151136121564498
Total current liabilities: 2,4362,2662,0882,1401,8551,751
Noncurrent Liabilities
Long-term debt and lease obligation     3639
Long-term debt, excluding current maturities     3639
Total noncurrent liabilities:     3639
Total liabilities: 2,4362,2662,0882,1401,8911,791
Stockholders' equity
Stockholders' equity attributable to parent (2,381)(2,128)(1,506)(750)(1,678)(1,432)
Preferred stock 626262167167167
Common stock 787787787787787698
Common stock, value, subscriptions 9999  
Additional paid in capital 48,87648,87648,87648,79248,74048,678
Accumulated deficit (52,115)(51,862)(51,240)(50,503)(51,373)(50,975)
Total stockholders' equity: (2,381)(2,128)(1,506)(750)(1,678)(1,432)
TOTAL LIABILITIES AND EQUITY: 551375821,391213359

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues   1  0
Revenue, net  0
Net investment income   1   
Cost of revenue (73)(142)(161)(1,538)(56)(116)
Cost of goods and services sold (11)(84)    
Gross profit: (73)(142)(159)(1,538)(56)(116)
Operating expenses 12(60)(75)1,373(83)(243)
Other undisclosed operating loss   (1)   
Operating loss: (61)(202)(236)(165)(139)(359)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
 (192)(420)(501)1,034(259) 
Interest and debt expense 25(198)100(2)(2)(2)
Income (loss) from continuing operations before equity method investments, income taxes: (228)(820)(637)867(400)(361)
Other undisclosed income (loss) from continuing operations before income taxes (25)198(100)22(107)
Net income (loss) available to common stockholders, diluted: (253)(622)(737)869(398)(468)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss): (253)(622)(737)869(398)(468)
Comprehensive income (loss), net of tax, attributable to parent: (253)(622)(737)869(398)(468)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: